ENO1 and breast carcinoma: Inhibition of enolase 1 expression can induce senescence in breast cancer cells but can support cell survival when glutamine metabolism is inhibited by the glutaminase inhibitor BPTES(bis-2-[5 phenylacetamino-1,2, 4-thiadiazole-2-yl] ethyl sulfide)[156].